Early research (Phase 1)Ended earlyNCT03548064
What this trial is testing
Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area
Who this might be right for
Gastroenteritis Escherichia ColiImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 75